Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty
暂无分享,去创建一个
J. Berlin | A. Turpie | S. Berkowitz | B. Levitan | R. Friedman | R. Weinstein | M. Homering | P. Dibattiste | Zhong Yuan | Peter M Dibattiste